1. Home
  2. OFIX vs UPB Comparison

OFIX vs UPB Comparison

Compare OFIX & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFIX
  • UPB
  • Stock Information
  • Founded
  • OFIX 1987
  • UPB 2021
  • Country
  • OFIX United States
  • UPB United States
  • Employees
  • OFIX N/A
  • UPB N/A
  • Industry
  • OFIX Medical/Dental Instruments
  • UPB
  • Sector
  • OFIX Health Care
  • UPB
  • Exchange
  • OFIX Nasdaq
  • UPB NYSE
  • Market Cap
  • OFIX 440.0M
  • UPB 521.3M
  • IPO Year
  • OFIX N/A
  • UPB 2024
  • Fundamental
  • Price
  • OFIX $10.84
  • UPB $10.66
  • Analyst Decision
  • OFIX Strong Buy
  • UPB Strong Buy
  • Analyst Count
  • OFIX 3
  • UPB 4
  • Target Price
  • OFIX $23.33
  • UPB $56.50
  • AVG Volume (30 Days)
  • OFIX 504.7K
  • UPB 397.6K
  • Earning Date
  • OFIX 05-06-2025
  • UPB 05-06-2025
  • Dividend Yield
  • OFIX N/A
  • UPB N/A
  • EPS Growth
  • OFIX N/A
  • UPB N/A
  • EPS
  • OFIX N/A
  • UPB N/A
  • Revenue
  • OFIX $804,529,000.00
  • UPB $2,296,000.00
  • Revenue This Year
  • OFIX $4.01
  • UPB N/A
  • Revenue Next Year
  • OFIX $6.08
  • UPB N/A
  • P/E Ratio
  • OFIX N/A
  • UPB N/A
  • Revenue Growth
  • OFIX 5.85
  • UPB N/A
  • 52 Week Low
  • OFIX $10.50
  • UPB $5.14
  • 52 Week High
  • OFIX $20.73
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • OFIX 27.95
  • UPB N/A
  • Support Level
  • OFIX $10.95
  • UPB N/A
  • Resistance Level
  • OFIX $11.72
  • UPB N/A
  • Average True Range (ATR)
  • OFIX 0.39
  • UPB 0.00
  • MACD
  • OFIX 0.00
  • UPB 0.00
  • Stochastic Oscillator
  • OFIX 2.84
  • UPB 0.00

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Share on Social Networks: